The Yankees’ biggest strength has turned into a problem at exactly the wrong time. What was supposed to be the backbone of the roster - the starting rotation - has slipped badly since June 1, when it has posted a 4.91 ERA. Injuries have played a part, and so has Will Warren running into a wall.
That’s why the trade deadline can’t just be about chasing the flashiest arm on the market. Yes, New York should have bigger names like Tarik Skubal and Joe Ryan on the board. But if the goal is to steady the club for the stretch run, the Yankees also need depth - real, usable depth - behind the young Warren, who is still learning on the job.
One of the more dependable options is Michael Wacha. He may not light up the radar gun or dominate highlight reels, but he brings something the Yankees could use right now: reliability.
The 34-year-old leads the majors with 114.2 innings pitched and owns a 3.45 ERA with 1.9 WAR, according to FanGraphs. With the Kansas City Royals headed toward a lost season, he could be available.
Wacha’s been in a different groove since 2022, when he’s put together a 3.46 ERA and 13 WAR across 715.2 innings. He also brings postseason experience, though the results there haven’t been pretty.
He has made 10 appearances and carries a 5.21 ERA, with most of that damage coming before the 2021 season. Still, he’s been around, pitching for the Padres, Boston, and even across town in Flushing with the Mets.
Reid Detmers offers a different kind of appeal. He’s the younger, higher-upside bet, and he’s under control through the 2029 season.
This year, he looks like he may finally be settling in as a starter. His 4.13 ERA is solid, but the 3.09 FIP tells a more encouraging story, and the strikeout-to-walk profile backs that up: 117 strikeouts against just 34 walks in 104.2 innings.
That kind of control comes at a price, though. Pitchers with years of team control do not come cheap, and Detmers still comes with real risk.
He hasn’t worked many big games, and the sample size is still small. There’s plenty to like, but the cost could be steep.
Then there’s Foster Griffin, whose path back to the majors has been anything but ordinary. Signed by the Royals at 18 in 2014, he finally got a brief look during the pandemic-shortened season, returned for another small stint in 2022, then went to the NPB before making it back. Now 30, he’s having a strong rookie season with the Washington Nationals.
In 110.1 innings, Griffin has posted a 2.77 ERA and 1.6 WAR. His strikeout rate, 23.8% according to Baseball Savant, sits in the 59th percentile, but his real strength is command.
His 6.2% walk rate ranks in the 84th percentile. Like Wacha, he brings plenty of experience, and there’s at least the possibility that all those years of waiting could fuel him if he gets a chance on a bigger stage.
For the Yankees, the deadline should be approached with caution and urgency at the same time. Will Warren may or may not bounce back.
Carlos Rodon may or may not return. With elbow-related injuries in the mix, the safest move is to plan as if neither happens.
In Other News...
Yankees Just Got Linked To A Trade Fans Will Hate Or Love
A speculative trade idea from Bleacher Report has the Yankees in an eye-catching spot, with the discussion centered on whether a utility infielder could be worth parting with a pair of pitching prospects. The appeal on New Yorks side is easy to see: Carlos Lagrange brings big arm strength and starter upside, while Eric Reyzelman has also drawn enough attention to be included in the kind of package that gets people talking.
Lagrange, in particular, has the sort of profile that makes these proposals divisive. The 23-year-old right-hander can reach 100 mph, pairs that heater with an above-average slider, and was effective in Triple-A before a shoulder injury complicated his season. On the other side of the idea sits Zack Gelof, a versatile infielder with years of team control and an .823 OPS, which is exactly why this kind of rumor can split a fan base right down the middle. [Read more 🡒]
Aaron Boone Finally Addressed The Anthony Volpe Confusion
The Yankees shortstop conversation has been noisy enough that it started to feel bigger than the actual depth chart, with Jose Caballeros name entering the debate and Anthony Volpe suddenly having to answer for a position he has long owned. Aaron Boone stepped in to calm some of that down, making clear that Volpe remains the clubs shortstop and treating him like the incumbent rather than a player fighting to keep a job.
Boones comments also helped separate the real baseball question from the rumor mill surrounding Volpes role. The Yankees have supported him as the starter, and while the chatter around a possible move has lingered, the team has not asked him to play elsewhere, leaving the focus where it belongs: on how the Yankees sort out the infield behind the guy they still view as their shortstop. [Read more 🡒]
A Forgotten Yankees Prospect From 2016 Is Back For The Worst Reason
A former Yankees pitching prospect from the 2016 system has resurfaced in an unwelcome way, this time in the Rockies Triple-A orbit. At 34, he is still hanging around professional baseball after a career that never quite matched the early buzz, one that took him out of the Yankees pipeline and eventually led to a major league debut with Oakland.
What makes the latest turn notable is less the uniform than the reason for it. The right-handers path has already included the usual grind of a fluctuating career, but now he is back in the news for a suspension tied to performance-enhancing drugs, a reminder that even players long removed from the spotlight can still leave one more awkward footnote behind. [Read more 🡒]